The Horizon for Treating Cutaneous Vascular Lesions

Amit M. Patel, Elizabeth L. Chou, Laura Findeiss, Kristen M. Kelly

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Dermatologists encounter a wide range of cutaneous vascular lesions, including infantile hemangiomas, port-wine stain birthmarks, arteriovenous malformations, venous malformations, Kaposi sarcomas, angiosarcomas, and angiofibromas. Current treatment modalities to reduce these lesions include topical and/or intralesional steroids, laser therapy, surgical resection, and endovascular therapy. However, each method has limitations owing to recurrence, comorbidities, toxicity, or lesion location. Photodynamic therapy, antiangiogenic therapy, and evolving methods of sclerotherapy are promising areas of development that may mitigate limitations of current treatments and offer exciting options for patients and their physicians.

Original languageEnglish (US)
Pages (from-to)98-104
Number of pages7
JournalSeminars in Cutaneous Medicine and Surgery
Volume31
Issue number2
DOIs
StatePublished - Jun 1 2012

Fingerprint

Blood Vessels
Skin
Port-Wine Stain
Angiofibroma
Hemangiosarcoma
Sclerotherapy
Kaposi's Sarcoma
Arteriovenous Malformations
Photochemotherapy
Laser Therapy
Therapeutics
Hemangioma
Comorbidity
Steroids
Physicians
Recurrence

All Science Journal Classification (ASJC) codes

  • Surgery
  • Dermatology

Cite this

The Horizon for Treating Cutaneous Vascular Lesions. / Patel, Amit M.; Chou, Elizabeth L.; Findeiss, Laura; Kelly, Kristen M.

In: Seminars in Cutaneous Medicine and Surgery, Vol. 31, No. 2, 01.06.2012, p. 98-104.

Research output: Contribution to journalReview article

Patel, Amit M. ; Chou, Elizabeth L. ; Findeiss, Laura ; Kelly, Kristen M. / The Horizon for Treating Cutaneous Vascular Lesions. In: Seminars in Cutaneous Medicine and Surgery. 2012 ; Vol. 31, No. 2. pp. 98-104.
@article{d22ff1a119044298adcaab29f0e3d5c7,
title = "The Horizon for Treating Cutaneous Vascular Lesions",
abstract = "Dermatologists encounter a wide range of cutaneous vascular lesions, including infantile hemangiomas, port-wine stain birthmarks, arteriovenous malformations, venous malformations, Kaposi sarcomas, angiosarcomas, and angiofibromas. Current treatment modalities to reduce these lesions include topical and/or intralesional steroids, laser therapy, surgical resection, and endovascular therapy. However, each method has limitations owing to recurrence, comorbidities, toxicity, or lesion location. Photodynamic therapy, antiangiogenic therapy, and evolving methods of sclerotherapy are promising areas of development that may mitigate limitations of current treatments and offer exciting options for patients and their physicians.",
author = "Patel, {Amit M.} and Chou, {Elizabeth L.} and Laura Findeiss and Kelly, {Kristen M.}",
year = "2012",
month = "6",
day = "1",
doi = "10.1016/j.sder.2012.02.001",
language = "English (US)",
volume = "31",
pages = "98--104",
journal = "Seminars in Cutaneous Medicine and Surgery",
issn = "1085-5629",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - The Horizon for Treating Cutaneous Vascular Lesions

AU - Patel, Amit M.

AU - Chou, Elizabeth L.

AU - Findeiss, Laura

AU - Kelly, Kristen M.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Dermatologists encounter a wide range of cutaneous vascular lesions, including infantile hemangiomas, port-wine stain birthmarks, arteriovenous malformations, venous malformations, Kaposi sarcomas, angiosarcomas, and angiofibromas. Current treatment modalities to reduce these lesions include topical and/or intralesional steroids, laser therapy, surgical resection, and endovascular therapy. However, each method has limitations owing to recurrence, comorbidities, toxicity, or lesion location. Photodynamic therapy, antiangiogenic therapy, and evolving methods of sclerotherapy are promising areas of development that may mitigate limitations of current treatments and offer exciting options for patients and their physicians.

AB - Dermatologists encounter a wide range of cutaneous vascular lesions, including infantile hemangiomas, port-wine stain birthmarks, arteriovenous malformations, venous malformations, Kaposi sarcomas, angiosarcomas, and angiofibromas. Current treatment modalities to reduce these lesions include topical and/or intralesional steroids, laser therapy, surgical resection, and endovascular therapy. However, each method has limitations owing to recurrence, comorbidities, toxicity, or lesion location. Photodynamic therapy, antiangiogenic therapy, and evolving methods of sclerotherapy are promising areas of development that may mitigate limitations of current treatments and offer exciting options for patients and their physicians.

UR - http://www.scopus.com/inward/record.url?scp=84861535887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861535887&partnerID=8YFLogxK

U2 - 10.1016/j.sder.2012.02.001

DO - 10.1016/j.sder.2012.02.001

M3 - Review article

VL - 31

SP - 98

EP - 104

JO - Seminars in Cutaneous Medicine and Surgery

JF - Seminars in Cutaneous Medicine and Surgery

SN - 1085-5629

IS - 2

ER -